XOMA Royalty (XOMA) Interest Coverage Ratio (2011 - 2026)
XOMA Royalty's (XOMA) quarterly Interest Coverage Ratio came in at 0.14 in Q1 2026, down 108.36% year-on-year from 1.71 in Q1 2025, and up 82.84% quarter-over-quarter from 0.83 in Q4 2025.
XOMA Royalty (XOMA) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
XOMA Royalty has disclosed Interest Coverage Ratio across 14 years of filings, most recently posting 0.14 for Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 0.14, down 108.36% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.02 (up 101.07% YoY), and the FY2025 annual result was 0.51, up 117.75% from the prior year.
- Interest Coverage Ratio came in at 0.14 for Q1 2026 at XOMA Royalty, up from 0.83 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1.71 in Q1 2025 to a low of 4.48 in Q3 2024.
- The 3-year median for Interest Coverage Ratio is 0.83 (2025), against an average of 1.09.
- Across the five-year window, Interest Coverage Ratio surged 186.7% in 2025 and tumbled 108.36% in 2026, its largest moves.
- XOMA Royalty's Interest Coverage Ratio stood at 2.14 in 2024, then jumped by 61.03% to 0.83 in 2025, then soared by 82.84% to 0.14 in 2026.
- The last three Interest Coverage Ratio figures came in at 0.14 (Q1 2026), 0.83 (Q4 2025), and 0.4 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -258.33 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 11.79 |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | -0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.14 |
| Dec 31, 2025 | -0.83 |
| Sep 30, 2025 | -0.40 |
| Jun 30, 2025 | 1.42 |
| Mar 31, 2025 | 1.71 |
| Dec 31, 2024 | -2.14 |
| Sep 30, 2024 | -4.48 |
| Jun 30, 2024 | -2.96 |
| Mar 31, 2024 | -1.97 |
| Jun 30, 2021 | -17.81 |
| Mar 31, 2021 | -22.24 |
| Dec 31, 2020 | 66.31 |
| Sep 30, 2020 | -6.20 |
| Jun 30, 2020 | -6.20 |
| Mar 31, 2020 | -10.36 |
| Dec 31, 2019 | -6.86 |
| Sep 30, 2019 | 5.97 |
| Jun 30, 2019 | -11.14 |
| Mar 31, 2019 | 4.51 |
| Dec 31, 2018 | -9.38 |